Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells

Cancer Research

Volumn 59, Issue 19, 1999, Pages 5047-5053

  Rizzo, Maria Teresa ^a   Regazzi, Ester ^c   Garau, Daniela ^c   Akard, Luke ^a   Dugan, Michael ^a   Boswell, H Scott ^b   Rizzoli, Vittorio ^c   Carlo Stella, Carmelo ^c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; ARACHIDONIC ACID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BURST FORMING UNIT E; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

5,8,11,14-EICOSATETRAYNOIC ACID; ADULT; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ARACHIDONIC ACID; BONE MARROW CELLS; CAFFEIC ACIDS; CELL DIVISION; COLONY-FORMING UNITS ASSAY; ERYTHROID PROGENITOR CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; INDOMETHACIN; KETOCONAZOLE; LEUKEMIA, MYELOID, CHRONIC; MALE; MICE; MIDDLE AGED; NORDIHYDROGUAIARETIC ACID; TUMOR CELLS, CULTURED;

EID: 0033215235     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Daley, G., Van Etten, R. A., and Baltimore, D. Induction of chronic myelogenous leukemia in mice by the p210 bcr-abl gene of the Philadelphia chromosome. Science (Washington DC), 247: 824-830, 1990.
2. Shannon, K. The Ras signaling pathway and the molecular basis of myeloid leukemogenesis. Curr. Opin. Hematol. 2: 305-308, 1995.
3. Dazzi, F., Capelli, D., Hasserjian, R., Corbo, M., Poletti, A., Chinswangwatanakul, W., Goldman, J. M., and Gordon, M. Y. The kinetics and extent of engraftment of chronic myeloid leukemia (CML) cells in NOD/SCID mice reflect the phase of the donor's disease: an in vivo model of CML biology. Blood, 92: 1390-1396, 1998.
4. 1-to-S phase transition in hematopoietic cells. Oncogene, 15: 2333-2342, 1997.
5. Salgia, R., Li, J-L., Ewaniuk D. S., Pear, W., Pisick, E., Burky, S. A., Ernst, T., Sattler, M., Chen, L. B., and Griffin, J. D. BCR-ABL induces multiple abnormalities of cytoskeleton function. J. Clin. Invest., 100: 46-57, 1997.
6. Stryckmans, P., Debusscher, L., and Socquet, M. Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia. Cancer Res., 36: 3034-3038, 1976.
7. Eaves, A. C., Cashman, J., Gaboury, L. A., Kalousek, D. K., and Eaves, C. J. Unregulated proliferation of primitive chronic myelogenous leukemia progenitors in the presence of normal marrow adherent cells. Proc. Natl. Acad. Sci. USA, 83: 5306-5310, 1986.
8. Bedi, A., Zehnbauer, B., Barber, J. P., Sharkis, S. J., and Jones, R. J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83: 2938-2944, 1994.
9. McGahon, A., Bissonette, R., Schmitt, M., Cotter, K. M., Green, D. R., and Cotter, T. G. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83: 1179-1187, 1994.
10. Smetsers, T. F., van de Locht, L., Pennings, A. H., Wessels, H. M., de Witte, T., and Mensink, E. J. Phosphorothionate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels. Leukemia (Baltimore), 9: 118-130, 1994.
11. Carlo-Stella, C., Dotti, G., Mangoni, L., Regazzi, E., Garau, D., Bonati, A., Almici, C., Sammarelli, G., Savoldo, B., Rizzo, M. T., and Rizzoli, V. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. Blood, 88: 3091-3100, 1996.
12. Amos, T. S., Lewis, J. L., Grand, F. H., Gooding, R. P., Goldman, J. M., and Gordon, M. Y. Apoptosis in chronic myeloid leukemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids. Br. J. Haematol., 91: 387-393, 1995.
13. Piomelli, D. Arachidonic acid in cell signaling. Curr. Opin. Cell. Biol., 5: 274-280, 1993.
14. 2 and arachidonic acid release in signal transduction. Biochem. Soc. Trans., 18: 503-507, 1990.
15. Di Marzo, V. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prostaglandins Leukotrienes Essent. Fatty Acids, 53: 239-254, 1995.
16. Rizzo, M. T., and Carlo-Stella, C. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-α induced activation of the c-jun amino terminal kinase in stromal cells. Blood, 88: 3792-3800, 1996.
17. Rao, N. G., Baas, A., Glasgow, W. C., Eling, T. E., Runge, M. S., and Alexander, R. W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem., 269: 32586-32591, 1994.
18. Seatter, S. D., Gilbert, J. J., and Harnett, M. M. Lipid signaling in lymphocyte activation and cell death. Biochem. Soc. Trans., 25 (Suppl.): 300S, 1997.
19. Madhavi, N., Das, U. N., Prabha, P. S., Kumar, G. S., Koratkar, R., and Sagar, P. S. Suppression of human T-cell growth in vitro by cis-unsaturated fatty acids: relationship to free radicals and lipid peroxidation. Prostaglandins Leukotrienes Essent. Fatty Acids, 51: 33-40, 1993.
20. Finstad, H. S., Kolset, S. O., Holme, J. A., Wiger, R., Ostulnd Farrants, A. K., Blomhoff, R., and Drevon, C. A. Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. Blood, 84: 3799-3809, 1994.
21. Koller, M., Wachtler, P., David, A., Muhr, G., and Konig, W. Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes. Inflammation, 21: 463-473, 1997.
22. Tang, D. G., Chen, Y. Q., and Honn, K. V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA, 93: 5241-5246, 1996.
23. Anderson, K. M., Seed, T., Jajeh, A., Dudeja, P., Byun, T., Meng, J., Ou, D., Bonomi, P., and Harris, J. E. An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells. Anticancer Res., 16: 2589-2600, 1996.
24. Mandanas, R. A., Leibowitz, D., Gharehbaghi, K., Tauchi, T., Burgess, G. S., Miyazawa, K., Jayaram, H. N., and Boswell, H. S. Role of p21 RAS in p210bcr-abl transformation of murine myeloid cells. Blood, 82: 1838-1847, 1993.
25. Savoldo, B., Sammarelli, G., Dotti, G., Garau, D., Regazzi, E., Cilloni, D., Tabilio A, Rizzoli, V., and Carlo-Stella, C. Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells. Leukemia (Baltimore), 12: 434-440, 1998.
26. Carlo-Stella, C., Regazzi, E., Garau, D., Mangoni, L., Rizzo, M. T., Bonati, A., Dotti, G., Almici, C., and Rizzoli, V. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. Br. J. Haematol., 93: 551-557, 1996.
27. Sutherland, H. J., Eaves, C. J., Lansdorp, P. M., Tacker, J. D., and Hogge, D. E. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood, 78: 666-672, 1993.
28. Udomsakdi, C., Eaves, C. J., Swolin, B., Reid, D. S., Barnett, M. J., and Eaves, A. C. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc. Natl. Acad. Sci. USA, 89: 6192-6196, 1992.
29. Herrmann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W., and Kalden, J. R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res., 22: 5506-5507, 1994.
30. Majno, G., and Joris, I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol., 146: 3-15, 1995.
31. Anderson, K. M., Ondery, F., and Harris, J. E. Arachidonic acid analogues: An additional class of membrane-active agents with potential anticancer activity. Prostaglandins Leukotrienes Essent. Fatty Acids, 35: 231-241, 1989.
32. Raff, M. Cell suicide for beginners. Nature (Lond.), 396: 119-122, 1998.
33. Thompson, C. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
34. Pan, H., Yin, C., and van Dyke, T. Apoptosis and cancer mechanisms. Cancer Surv., 29: 305-327, 1997.
35. Matthias, S., and Kolesnick, R. Ceramide: a novel second messenger. Adv. Lipid Res., 25: 65-90, 1993.
36. Maguer-Satta, V., Burl, S., Liu, L., Damen, J., Chahine, H., Kristal, G., Eaves, A., and Eaves, C. BCR-ABL accelerates C2-ceramide-induced apoptosis. Oncogene, 16: 237-248, 1998.
37. Rizzo, M. T., Boswell, H. S., Mangoni, L., Carlo-Stella, C., and Rizzoli, V. Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-α: evidence for a tyrosine-kinase-dependent process. Blood, 86: 2967-2975, 1995.
38. Rizzo, M. T., and Boswell, H. S. Regulation of interleukin-1 and tumor necrosis factor-α induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism. Exp. Hematol., 22: 87-94, 1994.
39. Chilton, F. H., Surette, M. E., and Winkler, J. D. Arachidonate-phospholipid remodeling and cell proliferation. Adv. Exp. Med. Biol., 416: 169-172, 1996.
40. 2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J. Biol. Chem., 272: 30504-30511, 1997.
41. Anderson, K. M., Seed, T., Plate, J. M., Jajeh, A., Meng, J., and Harris, J. E. Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis. Leuk. Res., 19: 789-801, 1995.
42. Williams, J. R., Leaver, H. A., Ironside, J. W., Miller, E. P., Whittle, I. R., and Gregor, A. Apoptosis in human primary brain tumors: actions of arachidonic acid. Prostaglandins Leukotrienes Essent. Fatty Acids, 58: 193-200, 1998.
43. Seegers, J. C., de Kock, M., Lottering, M. L., Grobler, C. J. S., van Papendorp, D. H., Shou, Y., Habbersett, R., and Lehnert, B. E. Effects of γ-linolenic acid and arachidonic acid on cell cycle progression and apoptosis induction in normal and transformed cells. Prostaglandins Leukotrienes Essent. Fatty Acids, 56: 271-280, 1997.
44. Begin, M. E., Das, U. N., Ells, G., and Horrobin, D. F. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukotrienes Essent. Fatty Acids, 19: 177-186, 1985.
45. Cheeseman, K. H., Burton, G. W., and Ingold, K. U. Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol. Pathol., 12: 235-239, 1984.
46. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexposing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
47. Brown, D. M., Warner, G. L., Ales-Martinez, J. E., Scott, D. W., and Phipps, R. P. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clin. Immunol. Immunopathol., 63: 221-229, 1992.
48. Stenke, L., Lauren, L., Reizenstein, P., and Lindgren, J. A. Leukotriene production by fresh human bone marrow cells: evidence of altered lipoxygenase activity in chronic myelocytic leukemia. Exp. Hematol., 15: 203-207, 1987.
49. 2 is not involved in Fas-mediated apoptosis. Eur. J. Biochem., 236: 533-538, 1996.
50. Korystov, Y. N., Dobrovinskaya, O. R., Shaposhnikova, V., and Eidus, L. K. Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation. FEBS Lett., 388: 238-241, 1996.
51. Morisaki, N., Sprecher, H., Milo, G. E., and Cornwell, D. G. Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis. Lipids, 17: 893-899, 1982.
52. Skulachev, V. P. Cytochrome c in the apoptotic and amioxidant cascades. FEBS Lett., 423: 275-280, 1998.
53. Naves Diaz, M. L., Elorriaga, R., Canteros, A., and Cannata Andia, J. B. Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity. Nephrol. Dial. Transplant., 13: 23-28, 1998.